MTOR and non-small cell lung carcinoma: In non-small cell lung cancer, upregulation of miR-1271 contributes to the inhibition of cancer development both in vitro and in vivo by downregulation the expression of its target gene mechanistic target of rapamycin (mTOR) [28].